Breast Cancer
New drug combination recommended by NICE for women with advanced her2+ breast cancer following Royal Marsden trial
The National Institute for Health and Care Excellence (NICE) has recommended tucatinib, a type of targeted treatment, in combination with trastuzumab, another targeted treatment, and capecitabine, a chemotherapy, for previously treated patients with HER2-positive locally advanced or metastatic breast cancer.
Read more
Breast Cancer
Royal Marsden is first in UK to use new breast tumour localisation device
Developed by Sirius Medical, a Netherlands Cancer Institute spin-off, Sirius Pintuition consists of a small magnetic seed - the size of a grain of rice - and a detector.
Breast Cancer
Leading breast cancer researcher elected as Fellow of the Academy of Medical Sciences
Professor Nicholas Turner has been recognised with a prestigious Fellowship of the Academy of Medical Sciences for his excellence in breast cancer research and outstanding contribution to the field.
Breast Cancer
Three-drug combination moves forward for advanced breast cancer
A combination of three drugs is safe and shows signs of effectiveness in treating some patients with previously treated advanced breast cancer, a clinical trial shows.
Breast Cancer
Watch the video: How to do a breast examination
Jenny Rusby, Consultant Oncoplastic Breast Surgeon at The Royal Marsden, demonstrates how to do a breast examination